Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Physician Champion

Ed Septimus, MD, FACP, FIDSA, FSHEA
Medical Director Infection Prevention and Epidemiology

Source: HCA Clinical Services Group, Nashville, TN

Selection

  • Basic knowledge of antibiotics
  • Must show interest in taking a leadership role in their local community
  • Respected by his or her peers
  • Good interpersonal skills
  • Good team player
  • Basic understanding of human factors and culture transformation
  • Should be paid

Top of Page

Development and implementation:

Phase 1

  • Education-academic detailing one-on-one or in small groups best sustainable approach (clinical decision support when available in Meditech)
  • Formulary management which responds to local patterns
  • Teaching to facilitate understanding and use of antibiograms
  • Microbiology partnership-review local lab methods (must be able to detect ESBL, hVISA, KPCs etc.)
  • Adoption of locally customized published practiced guidelines with measurements.  These must be continually reviewed and updated.  Below are a few for consideration: (prophylaxis and treatment building on core measures)
    • CAP
    • SIP
    • CR-BSI
    • UTI (look at treatment of asymptomatic bacteriuria)
    • CDI
  • Standardize definition and diagnosis of an infection based on national guidelines and NHSN definitions
  • Colonization vs. contamination
  • Approve criteria for IV to PO conversion
  • Based on cost analysis implement criteria for linezolid and echinocandins use (use either front-end or back-end approach based on local resources and culture)

Top of Page

Phase 2

  • Surviving sepsis protocol
  • Empiric therapy guidelines based on local antibiograms
  • De-escalation after 72 hours based on pathogen specific diagnosis-may want to start with only positive blood cultures
  • Renal and hepatic dosing (could be in phase 1)
  • Antimicrobial optimization to include weight-based dosing, pharmacokinetics, and duration
  • Review all patients on ≥3 antibiotics for 72 hours, duration >10 days, microbiology mismatches
  • Add additional drug reviews based on prescribing patterns and cost (e.g. daptomycin, tigycycline)
  • Review expanded application of molecular diagnostics (MRSA, MSSA, CDI, VRE etc.)
  • Vaccine preventable infections

Top of Page

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #